{"id":"https://openalex.org/W2036675949","doi":"https://doi.org/10.1007/bf02171588","title":"Methylhydrazine derivatives, a new class of cytotoxic agents","display_name":"Methylhydrazine derivatives, a new class of cytotoxic agents","alternate_titles":[],"publication_year":1963,"publication_date":"1963-03-01","ids":{"openalex":"https://openalex.org/W2036675949","doi":"https://doi.org/10.1007/bf02171588","mag":"2036675949","pmid":"https://pubmed.ncbi.nlm.nih.gov/14003433"},"language":"en","primary_location":{"id":"doi:10.1007/bf02171588","doi":"https://doi.org/10.1007/bf02171588","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf02171588","pdf_url":"https://link.springer.com/content/pdf/10.1007/BF02171588.pdf","source":{"id":"https://openalex.org/S60362788","display_name":"Cellular and Molecular Life Sciences","issn_l":"1420-682X","issn":["1420-682X","1420-9071"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2036675949"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007/BF02171588.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113550974","display_name":"P. Zeller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Zeller","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111969339","display_name":"Heike Gutmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Gutmann","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061776250","display_name":"B. Heged\u00fcs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Heged\u00fcs","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003024413","display_name":"Ado Kaiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Kaiser","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042046611","display_name":"Albert Langemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Langemann","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":null,"display_name":"M. M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. M\u00fcller","raw_affiliation_strings":["Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemische Forschungsabteilung, F. Hoffmann-La Roche & Co. AG., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":null,"fwci":10.6878,"has_fulltext":true,"cited_by_count":91,"citation_normalized_percentile":{"value":0.99500192,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"19","issue":"3","first_page":"129","last_page":"129"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0142000000923872,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.7850000262260437},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9079999923706055},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hydrazine-hydrochloride","display_name":"hydrazine hydrochloride","score":0.7680000066757202},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2908896964","wikidata":"https://www.wikidata.org/wiki/Q6824016","display_name":"Methylhydrazine","level":3,"score":0.7189897298812866},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45649614930152893},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.43549612164497375},{"id":"https://openalex.org/C2776098391","wikidata":"https://www.wikidata.org/wiki/Q290862","display_name":"Phenylhydrazine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003603","descriptor_name":"Cytotoxins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009002","descriptor_name":"Monomethylhydrazine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf02171588","doi":"https://doi.org/10.1007/bf02171588","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf02171588","pdf_url":"https://link.springer.com/content/pdf/10.1007/BF02171588.pdf","source":{"id":"https://openalex.org/S60362788","display_name":"Cellular and Molecular Life Sciences","issn_l":"1420-682X","issn":["1420-682X","1420-9071"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"journal-article"},{"id":"pmid:14003433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14003433","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/bf02171588","doi":"https://doi.org/10.1007/bf02171588","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf02171588","pdf_url":"https://link.springer.com/content/pdf/10.1007/BF02171588.pdf","source":{"id":"https://openalex.org/S60362788","display_name":"Cellular and Molecular Life Sciences","issn_l":"1420-682X","issn":["1420-682X","1420-9071"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2036675949.pdf","grobid_xml":"https://content.openalex.org/works/W2036675949.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W1998956533","https://openalex.org/W2029894440","https://openalex.org/W2069874395"],"related_works":["https://openalex.org/W2069874395","https://openalex.org/W1985382135","https://openalex.org/W2016932842","https://openalex.org/W2001535931","https://openalex.org/W2430563541","https://openalex.org/W4211207259","https://openalex.org/W2332644799","https://openalex.org/W1576527895","https://openalex.org/W2130064076","https://openalex.org/W2092120859"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2036675949","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
